TheProfitWatch

CNTB - Connect Biopharma Holdings Limited Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.98 0.08 (2.68%) --- 0.0 (0.0%) -0.08 (-2.55%) --- 0.08 (2.68%) -0.07 (-2.31%) -0.07 (-2.31%)

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.19
Diluted EPS:
-0.19
Basic P/E:
-16.1053
Diluted P/E:
-16.1053
RSI(14) 1m:
29.75
VWAP:
3.07
RVol:

Events

Period Kind Movement Occurred At

Related News